Loading
Alphavirus Infections / Swine Diseases · Journal article
Virulence · September 4, 2026
Raises a question worth testing. It does not answer one.
This is a mechanistic study identifying a conserved four-residue motif (NQVF) in the E1 glycoprotein stem as a virulence regulator in Getah virus using reverse genetics and neonatal mouse models. Complete deletion of this motif abolished lethality and systemic dissemination, suggesting potential vaccine target, but the work is preclinical and raises rather than answers questions about translational utility.
Experimental virology study combining reverse genetics, in vitro cell culture, and in vivo animal models. GETV variant source: brain tissue from diseased piglets. Experimental subjects: neonatal mice (lethality model), pregnant mice (vertical transmission model). No clinical subjects or human tissues.. Intervention: Reverse genetics-generated recombinant GETV with E1 stem deletion (9 nucleotides removing Q397, V398, N396I, F399) and stepwise single and combined deletions; recombinant GETV with NSP2 T49M mutation.. Compared with: Wild-type GETV and incremental single-deletion mutants to assess synergistic effect of four-residue motif.. Not stated in source text..
Natural GETV variant harbors 9-nucleotide deletion removing Q397 and V398, plus N396I substitution and F399 loss, in E1 stem region E1 deletion drastically attenuates viral replication in vitro and completely abrogates lethality in neonatal mice Quadruple deletion of NQVF motif confers full attenuation; single deletions only partially reduce pathogenicity
No data on immunogenicity, protection, or safety of a putative attenuated vaccine candidate
This is a basic research finding that identifies a potential vaccine design target but provides no clinical efficacy data. Professionals should recognize it as early mechanistic work; development of a candidate vaccine and its testing in relevant animal models or clinical trials would be necessary before clinical translation.
Mechanistic study using reverse genetics in cell culture and animal models to identify a virulence determinant; lacks clinical outcomes or efficacy data needed to guide vaccine development or clinical practice.
As stated by the source record.
Quoted from the source exactly as published.
This is a basic research finding that identifies a potential vaccine design target but provides no clinical efficacy data. Professionals should recognize it as early mechanistic work; development of a candidate vaccine and its testing in relevant animal models or clinical trials would be necessary before clinical translation.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
Getah virus (GETV) is an emerging arthropod-borne zoonotic alphavirus that poses a growing threat to animal and public health, yet its virulence determinants remain poorly understood. Here, we report the first identification of a natural GETV variant isolated from the brain of diseased piglets. This variant harbors a 9-nucleotide deletion in the E1 glycoprotein stem region, resulting in the deletion of glutamine 397 (Q397) and valine 398 (V398), along with an asparagine‑to‑isoleucine substitution at position 396 (N396I) and the loss of phenylalanine 399 (F399). It also carries a threonine-to-methionine substitution at position 49 (T49M) in nonstructural protein 2 (NSP2). The NQVF motif (residues 396-399) in E1 protein is highly conserved among GETV strains and related alphaviruses, suggesting a shared functional role. Using reverse genetics, we demonstrated that the E1 deletion-but not the NSP2 mutation-drastically attenuates viral replication in vitro and completely abrogates lethality in neonatal mice by restricting systemic dissemination. Stepwise mutagenesis further revealed that the four‑residue motif functions synergistically as a virulence switch: single deletions partially reduce pathogenicity, while the quadruple deletion confers full attenuation, limiting tissue tropism and histopathology. Although both wild‑type and mutant viruses crossed the placental barrier in pregnant mice, the mutant exhibited reduced vertical transmission and maternal tissue replication. Our findings identify a highly conserved E1 stem motif as a critical regulator of GETV virulence, offering a strategic target for developing attenuated vaccines against GETV and other alphaviruses.
Taken from the source record, never inferred. Follow any of these and new work involving them reaches your briefing.